U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.
GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down
Related Posts
Popular News
Latest News
Electric vehicle giant BYD predicts 80% of China car sales will soon be electric
08 September 2025, Bavaria, Munich: Stella Li, Vice President of the car manufacturer BYD, speaks during a presentation by the...
You Will Finally Be Able to Share iCloud Photo Albums With Android and Windows Users
During the WWDC 2027 keynote, Apple announced that it's making iCloud Shared Albums more useful. This feature will now support...
New XRP Lending Protocol Gets Formal Verification In Push For Safer DeFi
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure RippleX Developers said formal verification work on...
Dollar eases as investors weigh Middle East hopes, rate outlook
Dollar eases as investors weigh Middle East hopes, rate outlook
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.